Cardiovascular Medical Science Liaison - Field (60% Travel)

The Medical Affairs Company (TMAC); Dallas (TX); Sur place; USD 120 000 - 170 000; Plein temps

Résumé du poste

The Medical Affairs Company (TMAC) is seeking a Medical Science Liaison (MSL) to serve as a field-based extension of the company. The MSL will engage in scientific discussions with external stakeholders about cardiovascular disease and the evidence supporting TMAC's portfolio, including a PCSK9 inhibitor used with diet and exercise.

Key duties include supporting medical communications and publications, assessing KOL alignment to inform territory strategy, staying current with literature, and

Qualifications

• Advanced scientific, clinical, or healthcare-related degree preferred or equivalent experience.
• Experience in the pharmaceutical industry, Medical Affairs, or a cardiovascular-focused clinical setting.
• Thorough knowledge of medicine, treatment guidelines, clinical research processes, customer strategies, and FDA guidelines.
• Ability to access and develop relationships with high-level stakeholders.
• Effective communication of scientific content 1:1, in small groups, and in writing.
• Strong team player with cross-department collaboration.

Responsabilités

• Engage in scientific discussions with external stakeholders about disease state and supporting evidence.
• Support medical communications and publications by liaising between external and internal stakeholders.
• Assess KOL alignment to inform territory and medical strategy.
• Stay current with emerging literature and translate data into knowledge exchange.
• Collect scientific and clinical insights to support information sharing across the organization.
• Travel up to 60% and thrive in a dynamic small-company environment.

Connaissances

Scientific communication

Stakeholder engagement

Clinical data interpretation

Team collaboration

Formation

MD/PhD/PharmD/PA/NP/MSN or equivalent

Description du poste

The Medical Affairs Company (TMAC) is seeking a Medical Science Liaison (MSL) to serve as a field-based extension of the company. The MSL will engage in scientific discussions with external stakeholders about cardiovascular disease and the evidence supporting TMAC's portfolio, including a PCSK9 inhibitor used with diet and exercise.

Key duties include supporting medical communications and publications, assessing KOL alignment to inform territory strategy, staying current with literature, and